{
    "Trade/Device Name(s)": [
        "BinaxNOW\u00ae Malaria Positive Control",
        "BinaNOW\u00ae Malaria Positive Control",
        "Binax NOW\u00ae Malaria Positive Control",
        "NOW\u00ae Malaria Positive Control"
    ],
    "Submitter Information": "Binax, Inc., d/b/a Inverness Medical",
    "510(k) Number": "K083744",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "MJZ"
    ],
    "Summary Letter Date": "July 30, 2009",
    "Summary Letter Received Date": "August 4, 2009",
    "Submission Date": "December 12, 2008",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality Control Material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Histidine-rich protein II (HRP II)",
        "pan-malarial protein"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "BinaxNOW\u00ae Malaria Test"
    ],
    "Method(s)/Technology(ies)": [
        "Recombinant antigen control",
        "Antigen detection"
    ],
    "Methodologies": [
        "Qualitative antigen detection"
    ],
    "Submission Type(s)": [
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for BinaxNOW\u00ae Malaria Positive Control, a recombinant antigen positive control for use with the BinaxNOW\u00ae Malaria Test.",
    "Indications for Use Summary": "Intended for use as an assayed positive external quality control with the qualitative BinaxNOW\u00ae Malaria Test to aid in verifying proper performance of the procedure and antigen detection reagents.",
    "fda_folder": "Clinical Chemistry"
}